TVTX
USDTravere Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$32.600
Máximo
$34.605
Mínimo
$32.310
Volumen
0.26M
Fundamentos de la Empresa
Capitalización de Mercado
3.1B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.25M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Travere Therapeutics to Participate at Upcoming Investor Conferences
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.
Travere Therapeutics to Report Third Quarter 2025 Financial Results
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.